Search
for
Sort by
Research 781–810 of 1000+
- LB1048 Effectiveness of OR-101 in a murine model of atopic dermatitis
- 6ER-014 Evaluation of baricitinib in paediatric patients with alopecia areata
- In Silico Structure-Based Drug Design Approach To Evaluate Quercetin And Kaempferol As Dual Inhibitors Of Jak3 Kinase And 5-Alpha Reductase Type II with ADMET Profiling
- In Silico Structure-Based Drug Design Approach To Evaluate Quercetin And Kaempferol As Dual Inhibitors Of Jak3 Kinase And 5-Alpha Reductase Type II with ADMET Profiling
- A phase 2a trial of brepocitinib for cicatricial alopecia
- Hair follicle targeting via gelatin coated transferosomes loaded with tofacitinib citrate for enhanced treatment of alopecia areata: Clinical evaluation of alopecia areata patients
- Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?
- Increased proliferation of epidermal gamma delta T cells and expression of the transmembrane protein, BST2, in Alopecia areata
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Application of Baricitinib in Dermatology
- Hair Loss in Lichen Planopilaris and Frontal Fibrosing Alopecia: Not Always Irreversible
- Deciphering the molecular drivers for cashmere/pashmina fiber production in goats: a comprehensive review
- Disease-related biomarkers as experimental endpoints in 3D skin culture models
- Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib
- A Case of Topical Ruxolitinib Treatment Failure in Alopecia Areata
- A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision Making
- Reconsidering the classification of vitiligo and alopecia as cosmetic concerns in Medicaid and Tricare policies
- Analysing the dynamics of a model for alopecia areata as an autoimmune disorder of hair follicle cycling
- Hair regrowth in a patient with alopecia universalis and psoriasis vulgaris during deucravacitinib therapy
- Selective Expansion of Tregs Using the IL-2 Cytokine Antibody Complex Does Not Reverse Established Alopecia Areata in C3H/HeJ Mice
- Cell fate decisions: emerging roles for metabolic signals and cell morphology
- Hair regeneration using adipose-derived stem cells.
- Analysis of histology and long noncoding RNAs involved in the rabbit hair follicle density using RNA sequencing
- Causal relationship between inflammatory cytokines and polycystic ovary syndrome: a bidirectional mendelian randomization study
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Single-cell analysis of temporal immune cell dynamics in alopecia areata reveals a causal role for clonally expanded CD8+ T cells in disease
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Effectiveness and safety of Baricitinib in alopecia areata: a prospective cohort study
- Evaluating the Causal Relationship Between Human Blood Metabolites and the Susceptibility to Alopecia Areata
- Ex Vivo Treatment with Allogenic Mesenchymal Stem Cells of a Healthy Donor on Peripheral Blood Mononuclear Cells of Patients with Severe Alopecia Areata: Targeting Dysregulated T Cells and the Acquisition of Immunotolerance